Patent Issued for Methods and composition for neutralization of influenza (USPTO 12180267).

A patent has been issued for methods and compositions to neutralize influenza by targeting the neuraminidase protein. The University of Chicago inventors have developed antibodies that can cross-react with multiple influenza strains, potentially improving treatment and prevention of influenza infections. The patent focuses on isolating antibodies that neutralize influenza infection and inhibit neuraminidase activity, offering a new approach to combating the virus. [Extracted from the article]